| Trial ID: | L0267 |
| Source ID: | NCT00915876
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00915876/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Paricalcitol|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in Circulating ICAM-1 Shown by Absolute Values at Baseline, Day 28 and Day 56, Values of ICAM-1 (intracellular adhesion molecule) a measure of vascular reactivity, at three time points: baseline, day 28, and day 56, Day 28 and Day 56 |
|
| Sponsor/Collaborators: |
Sponsor: Amy Barton Pai | Collaborators: Albany College of Pharmacy and Health Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
41
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose:
|
| Start Date: |
2009-03
|
| Completion Date: |
2011-03
|
| Results First Posted: |
2016-12-02
|
| Last Update Posted: |
2016-12-02
|
| Locations: |
Albany Medical Center South Clinical Campus, Albany, New York, 12208, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00915876
|
